Amundi Index Solutions - Amundi Euro Stoxx 50 (ENXTPA:CD5) - Stock Price, News & Analysis

CD5 Stock Overview

Amundi Index Solutions - Amundi Euro Stoxx 50 is an exchange traded fund launched and managed by Amundi Asset Management.

About the company

CD5 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Amundi Index Solutions - Amundi Euro Stoxx 50 Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Amundi Index Solutions - Amundi Euro Stoxx 50
Historical stock prices
Current Share Price	US$81.33
52 Week High	US$81.55
52 Week Low	US$64.60
Beta	0
1 Month Change	3.92%
3 Month Change	10.07%
1 Year Change	17.70%
3 Year Change	28.26%
5 Year Change	52.59%
Change since IPO	55.72%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CD5	FR Capital Markets	FR Market
7D	2.8%	2.3%	2.3%
1Y	17.7%	10.2%	6.0%

Return vs Industry: CD5 exceeded the French Capital Markets industry which returned 10.2% over the past year.

Return vs Market: CD5 exceeded the French Market which returned 6% over the past year.

Price Volatility

Is CD5's price volatile compared to industry and market?
CD5 volatility
CD5 Average Weekly Movement	1.5%
Capital Markets Industry Average Movement	2.3%
Market Average Movement	4.4%
10% most volatile stocks in FR Market	9.8%
10% least volatile stocks in FR Market	2.2%

Stable Share Price: CD5 has not had significant price volatility in the past 3 months.

Volatility Over Time: CD5's weekly volatility (2%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2008	n/a	n/a	n/a

Amundi Index Solutions - Amundi Euro Stoxx 50 is an exchange traded fund launched and managed by Amundi Asset Management. The fund invests in the public equity markets of the Euro zone. It uses derivatives such as swaps to invest in the stocks of companies operating across diversified sectors.

Amundi Index Solutions - Amundi Euro Stoxx 50 Fundamentals Summary

How do Amundi Index Solutions - Amundi Euro Stoxx 50's earnings and revenue compare to its market cap?
CD5 fundamental statistics
Market cap	€13.53m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is CD5 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CD5 income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did CD5 perform over the long term?

See historical performance and comparison